Aimed Bio

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

N/A

Website

www.aimedbio.com

Country

South Korea

Exchange

KOSDAQ

Founded 2018

Aimed Bio develops therapeutic solutions for patients with brain diseases, including neuro-oncological and degenerative diseases. Its multidisciplinary platform offers antibody-drug conjugates, blood-brain barrier penetration, brain immune modulation, and patient-derived models (PDC/PDX). Founded in 2018, Aimed Bio is based in Seoul, South Korea.

Key Stats

52-Week Range

₩18330.00₩80200.00

BetaN/A

Trailing P/EN/A

Forward P/EN/A

Trailing EPSN/A

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.